SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Lotus Eye Hospital And Institute Ltd

BSE: 532998 NSE: LOTUSEYE ISIN: INE947I01017
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Lotus Eye Hospital And Institute Ltd belong to?
Lotus Eye Hospital And Institute Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Lotus Eye Hospital And Institute Ltd a good quality company?
Lotus Eye Hospital And Institute Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Lotus Eye Hospital And Institute Ltd undervalued or overvalued?
Lotus Eye Hospital And Institute Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Lotus Eye Hospital And Institute Ltd a good buy now?
Lotus Eye Hospital And Institute Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd revenue growth is 2.8% for FY-2025 , which is below its 5 year CAGR of 4.1% , indicating slower growth.
Q.2 Gross Profit margin of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Gross profit margin which is the profit after deduction of direct costs, is 8.8% for FY-2025 , which is below its 5 year median of 16.1% , indicating decreasing margins.
Q.3 Operating Profit Margin of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 7.18% for FY-2025 , which is below its 5 year median of 13.76% indicating decreasing margins.
Q.4 Net Profit Margin of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Net Profit Margin is 1.49% for FY-2025 , is below with its 5 year median of 6.05%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 8.8 16.1
Operating Profit Margin 7.18 13.76
Net Profit Margin 1.49 6.05
Q.5 Return on Asset of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Return on Asset is 1.09%, which is below its 5 year historical median of 4.51%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Return on equity is 1.24% for FY-2025 , which is below its historical median of 4.98%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Return on capital employed is 3.1% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Cash conversion cycle is 7 days, above its historical median of -7 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.73 0.73
ROE 1.24 4.98
ROCE 3.1 7.19
Cash Conversion Cycle 7 days -7 days
Q.9 Debt to Equity ratio of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Debt-to-Equity ratio is 0.01 , which is lower with the industry average of 0.22 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Lotus Eye Hospital And Institute Ltd?
Lotus Eye Hospital And Institute Ltd Debt to cash flow from operations is 0.22 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Lotus Eye Hospital And Institute Ltd?
Promoters hold 40.14% of the Lotus Eye Hospital And Institute Ltd, with 87.15% of their stake pledged, indicating high pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Lotus Eye Hospital And Institute Ltd vs industry peers?
Lotus Eye Hospital And Institute Ltd revenue CAGR is 4.09% , compared to the industry median CAGR of 1.49% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 49.6 144
Gross Profit 4.4 8.2
Operating Profit 4 8.4
Net Profit 1 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.73 0.73
ROE 1.24 13.88
ROCE 3.1 17.77
Cash Conversion Cycle (days) 6.75 2

Valuation & price assessment

Q.1 Stock return of Lotus Eye Hospital And Institute Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 21.3% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 21.3% 23.2% 27.6% 90.2%
Q.3 Valuation ratios of Lotus Eye Hospital And Institute Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 373.89 45.09 79.71
Price to Book 4.05 2.48 3.54
Price to Sales 4.73 3.11 4.37
EV to EBITDA 61.11 18.57 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Vijaya Diagnostic
8. Park Medi World
9. Metropolis Health.
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×